Molecular Therapy-methods & Clinical Development

Molecular Therapy-methods & Clinical Development

分子治疗方法和临床开发

  • 2区 中科院分区
  • Q2 JCR分区

期刊简介

《Molecular Therapy-methods & Clinical Development》是由Cell Press出版社于2014年创办的英文国际期刊(ISSN: 2329-0501,E-ISSN: 2329-0501),该期刊长期致力于医学:研究与实验领域的创新研究,主要研究方向为Biochemistry, Genetics and Molecular Biology-Molecular Biology。作为SCIE收录期刊(JCR分区 Q2,中科院 2区),本刊采用OA开放获取模式(OA占比1%),以发表医学:研究与实验领域等方向的原创性研究为核心(研究类文章占比94.59%%)。凭借严格的同行评审与高效编辑流程,期刊年载文量精选控制在0篇,确保学术质量与前沿性。成果覆盖Web of Science、Scopus等国际权威数据库,为学者提供推动医学领域高水平交流平台。

投稿咨询

投稿提示

Molecular Therapy-methods & Clinical Development审稿周期约为 12 Weeks 。该刊近年未被列入国际预警名单,年发文量约0篇,录用竞争适中,主题需确保紧密契合医学前沿。投稿策略提示:避开学术会议旺季投稿以缩短周期,语言建议专业润色提升可读性。

  • 医学 大类学科
  • English 出版语言
  • 是否预警
  • SCIE 期刊收录
  • 0 发文量

中科院分区

中科院 SCI 期刊分区 2023年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
2区

中科院 SCI 期刊分区 2022年12月升级版

Top期刊 综述期刊 大类学科 小类学科
医学
2区
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
2区

JCR分区

按JIF指标学科分区 收录子集 分区 排名 百分位
学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 54 / 136

60.7%

CiteScore

CiteScore SJR SNIP CiteScore 排名
CiteScore:9.9 SJR:1.896 SNIP:1.076
学科类别 分区 排名 百分位
大类:Biochemistry, Genetics and Molecular Biology 小类:Genetics Q1 43 / 347

87%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Biology Q1 75 / 410

81%

大类:Biochemistry, Genetics and Molecular Biology 小类:Molecular Medicine Q1 36 / 178

80%

期刊发文

  • Advancements and Obstacles of CRISPR-Cas9 Technology in Translational Research

    Author: Liting You, Mengqian Li, Ruizhan Tong, Yuncong Liu, Jianxin Xue, You Lu

    Journal: Molecular Therapy-Methods & Clinical Development, 2019, Vol., , DOI:10.1016/j.omtm.2019.02.008

  • Rational Design of Gene Therapy Vectors

    Author: Dao Pan, Hildegard Büning, Chen Ling

    Journal: Molecular Therapy-Methods & Clinical Development, 2019, Vol.12, 246-247, DOI:10.1016/j.omtm.2019.01.009

  • MicroRNA-96 Promotes Schistosomiasis Hepatic Fibrosis in Mice by Suppressing Smad7

    Author: Xufeng Luo, Dongmei Zhang, Jun Xie, Qin Su, Xing He, Ruipu Bai, Guangping Gao, Weiqing Pan

    Journal: Molecular Therapy-Methods & Clinical Development, 2018, Vol.11, 73-82, DOI:10.1016/j.omtm.2018.10.002

  • P-FN12, an H4R-Based Epitope Vaccine Screened by Phage Display, Regulates the Th1/Th2 Balance in Rat Allergic Rhinitis

    Author: Yuqian Wang, Jichao Sha, Heng Wang, Lifeng An, Tie Liu, Lin Li

    Journal: Molecular Therapy-Methods & Clinical Development, 2018, Vol.11, 83-91, DOI:10.1016/j.omtm.2018.09.004

  • A Robust System for Production of Superabundant VP1 Recombinant AAV Vectors

    Author: Qizhao Wang, Zhongren Wu, Junping Zhang, Jenni Firrman, Hongying Wei, Zhengjing Zhuang, LinShu Liu, Linqing Miao, Yang Hu, Dong Li, Yong Diao, Weidong Xiao

    Journal: Molecular Therapy-Methods & Clinical Development, 2017, Vol.7, 146-156, DOI:10.1016/j.omtm.2017.11.002

  • Production and clinical development of nanoparticles for gene delivery

    Author: Jie Chen, Zhaopei Guo, Huayu Tian, Xuesi Chen

    Journal: Molecular Therapy-Methods & Clinical Development, 2016, Vol.3, 16023, DOI:10.1038/mtm.2016.23

  • Syngeneic AAV Pseudo-particles Potentiate Gene Transduction of AAV Vectors

    Author: Qizhao Wang, Biao Dong, Katie A. Pokiniewski, Jenni Firrman, Zhongren Wu, Mario P.S. Chin, Xiongwen Chen, LinShu Liu, Ruian Xu, Yong Diao, Weidong Xiao

    Journal: Molecular Therapy-Methods & Clinical Development, 2017, Vol.4, 149-158, DOI:10.1016/j.omtm.2016.12.004

  • Increasing the minicircle DNA purity using an enhanced triplex DNA technology to eliminate DNA contaminants

    Author: Xiaohu H Hou, Xiaoyan Y Guo, Yusheng Chen, Cheng-Yi He, Zhi-Ying Chen

    Journal: Molecular Therapy-Methods & Clinical Development, 2015, Vol.2, 14062, DOI:10.1038/mtm.2014.62